Broj 5.

LITERATURA:

    1. Kostić V. Urednik. Neurologija za studente medicine. Medicinski fakultet u Beogradu. 2007.
    2. Motamedi G, Meador K. Epilepsy and cognition. Epilepsy Behav. 2003;4:25-38.
    3. Aldenkamp AP, Bodde N. Behavior, cognition and epilepsy. Acta Neurol Scand. 2005;182:19-25.
    4. Mazzini L, Cossa FM, Angelino E, Campini R, Pastore I, Monaco F. Posttraumatic epilepsy: neuroradiologic and neuropsychological assessment of long-term outcome. Epilepsia. 2003;44:569-74.
    5. Klein B, Levin BE, Duchowny MS, Llabre MM. Cognitive outcome of children with epilepsy and malformations of cortical development. Neurology. 2000;55:230-5.
    6. Hermann BP, Seidenberg M, Schoenfeld J, Davies K. Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy. Arch Neurol. 1997;54:369-76.
    7. Kilpatrick C, Murrie V, Cook M, Andrewes D, Desmond P, Hopper J. Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits. Seizure. 1997;6:213-8.
    8. Jović N. Neuropsihologija epilepsija razvojnog doba. Beograd. Grafomarket, 2000.
    9. DiMario FJ. Brain abnormalities in tuberous sclerosis complex. J Child Neurol. 2004;19:650-7.
    10. Blume WT. Lennox–Gastaut syndrome: potential mechanisms of cognitive regression. Ment Retard Dev Disabil Res Rev. 2004;10:150-3.
    11. Gordon N. The Landau–Kleffner syndrome: increased understanding. Brain Dev. 1997;19:311-6.
    12. Bulteau C, Jambaque I, Viguier D, Kieffer V, Dellatolas G, Dulac O. Epileptic syndromes, cognitive assessment and school placement. a study of 251 children. Dev Med Child Neurol 2000;42:319-27.
    13. Berg AT. Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. 2011;52:7-12.
    14. Berg AT, Zelko FA, Levy SR, Testa FMAge at onset of epilepsy, pharmacoresistance, and cognitive outcomes: A prospective cohort study. Neurology. 2012;79(13):1384-91.
    15. Strauss E, Loring D, Chelune G et al. Predicting cognitive impairment in epilepsy: findings from the Bozeman Epilepsy Consortium. J Clin Exp Neuropsychol. 1995;17:909-17.
    16. Kwan P, Brodie MJ. Neuropsychological effects and antiepileptic drugs. Lancet. 2001;357:216-22.
    17. Hendriks MPH, Aldenkamp AP, Alpherts WCJ, Ellis J, Vermeulen J, van der Vlugt H. Relationships between epilepsy-related factors and memory impairment. Acta Neurol Scand. 2004;10:1600-4.
    18. Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology. 2002;58:21-6.
    19. Bergin PS, Thompson PJ, Baxendale SA, Fish DR, Shorvon SD. Remote memory in epilepsy. Epilepsia. 2000;41:231-9.
    20. Giovagnoli AR, Avanzini G. Learning and memory impairment in patients with temporal lobe epilepsy: relation to the presence, type, and location of brain lesion. Epilepsia. 1999;40: 904-11.
    21. Loring DW, Hermann BP, Lee GP, Drane DL,Meador KJ. The Memory assessment Scales and lateralized temporal lobe epilepsy. J Clin Psychol. 2000;56:563-70.
    22. Baxendale SA, van Paesschen W, Thompson PJ, et al. The relationship between quantitative MRI and neuropsychological functioning in temporal lobe epilepsy. Epilepsia. 1998;39:158-66.
    23. Baxendale SA, Van Paesschen W, Thompson PJ, et al. Hippocampal cell loss and gliosis: relationship to preoperative and postoperative memory function. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11: 12-21.
    24. Sass KJ, Buchanan CP, Kraemer S, et al. Verbal memory impairment resulting from hippocampal neuron loss among epileptic patients with structural lesions. Neurology. 1995;45:2154-8.
    25. Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol. 1992;31: 629-37.
    26. Kilpatrick C, Murrie V, Cook M, et al. Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits. Seizure. 1997;6:213-8.
    27. Stretton J, Thompson PJ. Frontal lobe function in temporal lobe epilepsy. Epilepsy Res. 2012;98:1-13.
    28. Drake M, Allegri R and Thomson A, Executive cognitive alteration of prefrontal type in patients with mesial temporal lobe epilepsy. Medicina. 2000;60:453-56.
    29. Horner MD , Flashman L, Freides D, Epstein C and Bakay R, Temporal lobe epilepsy and performance on the Wisconsin Card Sorting Test. J. Clin. Exp. Neuropsychol. 1996;18:310-13.
    30. Giovanoli A.R. Relation of sorting impairment to hippocampal damage in temporal lobe epilepsy. Neuropsychologia. 2001;39:140-50.
    31. Helmstaedter C. Behavioral aspects of frontal lobe epilepsy. Epilepsy Behav. 2001;2:384–95.
    32. Springer JA, Binder JR, Hammeke TA, et al. Language dominance in neurologically normal and epilepsy subjects: a functional MRI study. Brain. 1999;122:2033–46.
    33. Rausch R, Victoroff J. Neuropsychological factors related to behavior disorders in epilepsy. In: Devinsky O, Theodore WH, eds. Epilepsy and behavior. Wiley-Liss. 1991;213-21.
    34. Mandelbaum DE, Burack GD. The effect of seizure type and medication on cognitive and behavioural functioning in children with idiopathic epilepsy. Dev Med Child Neurol. 1997;39:731-5.
    35. Dodril CB. Correlates of generalizedtonic-clonic seizures whit intellectual, neuropsychological emotional and social functionsin patiens whit epilepsy. Epilepsia. 1986;27:399-411.
    36. Vingerhoets G, Deblaere K, Backes WH, et al. Lessons for neuropsychology from functional MRI in patients with epilepsy. Epilepsy Behav. 2004;5:81-9.
    37. Manoach DS, Greve DN, Lindgren KA, Dale AM. Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI. Neuroimage. 2003;20: 1670-8.
    38. Aldenkamp AP, Beitler J, Arends J, van der Linden I, Diepman L. Acute effects of subclinical epileptiform EEG discharges on cognitive activation Funct Neurol. 2005;20(1):23-8.
    39. Binnie CD. Cognitive impairment–is it inevitable? Seizure. 1994; 3 Supll A:17-21.
    40. Binnie CD. Cognitive impairment during epileptiform discharges: is it ever justifiable to treat the EEG? Lancet Neurol. 2003;2:725-30.
    41. Baird HV, John ER, Ahn H, Maisel E. Neurometric evaluation of epileptic children who do well and poorly in school. Electroenceph clin Neurophisiol. 1980;48:683-91.
    42. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res. 1995;22:65-95.
    43. Ortinski P, Meador KJ. Cognitive side-effects of antiepileptic drugs. Epilepsy Behav 2004;5:60-5.
    44. Loring DW, Meador KJ. Cognitive and Behavioral Effects of Epilepsy Treatman. Epilepsia. 2001; 42(8):24-32.
    45. F. Gilliam, Optimizing health outcomes in active epilepsy. Neurology. 2002;58:9-20.
    46. Motamedi GK and Meador KJ. Antiepileptic drugs and memory. Epilepsy & Behavior. 2004;5:435-439.
    47. Albert P. Aldenkamp, Marc De Krom, and Rianne Reijs. Newer antiepileptic drugs and cognitive issues. Epilepsia. 2003;44:21-29.
    48. Aldenkamp AP. Effects of antiepileptic drugs on cognition Epilepsia. 2001;42:46.
    49. Jović JN. Antiepileptički lekovi i kognitivno funkcionisanje. Acta Med Pediat. 1997;1:143-158.
    50. Meador KJM, Loring DW, Huh K, et al. Comparative cognitive effects of anticonvulsants. Neurology. 1990;40:391-4.
    51. Thompson PJ, Huppert F, Trimble MR. Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand. 1980;80:75-80.
    52. Aldenkamp AP, Alpherts WCJ, Blennow G, et al. Withdrawal of antiepileptic medication: effects on cognitive function in children: the results of the multicentre „Holmfrid“ study. Neurology. 1993;43(1):41-50.
    53. Jokeit H, Okujava M and Woermann FG. Carbamazepine reduces memory induced activation of mesial temporal lobe structures: a pharmacological fMRI-study. BMC Neurol. 2001;1:6.
    54. Gallassi R, Morreale A, Di Sarro R, et al. Cognitive effects of antiepileptic drug discontinuation. Epilepsia. 1992;33:41-4.
    55. Meador KJM, Loring DW, Abney OL, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia. 1993;34:153-7.
    56. Meador KJ, Loring DW, Ray PG, et al., Differential cognitive effects of carbamazepine and gabapentin. Epilepsia. 1999;40:1279-1285.
    57. Meador KJ, Loring DW, Ray PG, Ray et al., Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology. 2001;56:1177-1182.
    58. Thompson PJ & Trimble MR. Sodium valproate and cognitive functioning in normal volunters. Br J Clin Pharmacol. 1981;12:819-24.
    59. Craig I & Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia. 1994;35:381-90.
    60. Prevey ML, Delaney RC, Cramer JA, et al. Effect of Valproate on cognitive function: comparison with carbamazepine: the Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol. 1996;53:1008-16.
    61. Kasteleijn-Nolst-TreniteD. Cognitive aspects. In Wallace S ed. Epilepsy in Children. Champan/Hall, London. 1996: 581-599.
    62. Trimble MR. Anticonvulsant drugs: mood and cognitive function. In: Trimble MR, Reynolds EH. eds. Epilepsy, Behavior and Cognitive function. John Willey & Sons, Chchester. 1988;135-43.
    63. Meador KJ, Loring DW, Allen ME, et al., Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology. 1991;41: 1537-40.
    64. Meador KJ, Loring DW, Moore EE, et al., Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy subjects. Neurology. 1995;45:1494-99.
    65. Forsythe I, Butler R, Berg I, et al. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol. 1991;33:524-34.
    66. Vining EP, Mellitis ED, Dorsen MM, et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-74.
    67. Calandre EP, Dominguez-Granados R, Gomez-Rubio M, et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand. 1990;81:504-6.
    68. Motamedi G and Meador K, Epilepsy and cognition. Epilepsy Behav. 2003;4:25-38.
    69. Ortinski P. and Meador KJ. Cognitive side effects of antiepileptic drugs. Epilepsy & Behavior. 2004;5:60-65.
    70. Uvebrand P, Bauzine R. Intractable epilepsy in children. The efficacy of lemotrigine treatma, including non-seazure-related benefits. Neuropediatrics. 1994;25:284-289.
    71. D. Smith, G. Baker, G. Davies, M. Dewey and D.W. Chadwick, Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993; 34: 312–322.
    72. Buchanan N. The efficasy of lamotrigine on seazure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure. 1995; 4: 233-236.
    73. Aldenkamp AP, Arends J, Bootsma HP, Diepman L, Hulsman J et al., Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia. 2002;43:19-26.
    74. Steiner TJ, Dellaportas CI, Findley LJ, et al., Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia. 1999; 40: 601–7.
    75. Meador KJ, Loring DW, Vahle VJ, Ray PG, Verz MA, Fessler AJ, et al. Gognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology. 2005; 64: 2108-14.
    76. Kockelmann E, Elger ChE and Helmstaedter Ch. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy & Behavior. 2004; 5: 716-21.
    77. McKee JR, Sunder TR, Vuong A, Hammer AE.Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation. J Child Neurol. 2006;21(5):372-9.
    78. Cramer JA, Fisher R, Ben-Menachem E, et al. New antiepileptic drugs: comparison of key clinical trials. Epilepsia. 1999;40:590-600.
    79. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther. 1997;19:1294–308.
    80. Lee S, Sziklas V, Andermann F, Farnham S, Risse G, Gustafson M. The Effects of Adjunctive Topiramate on Cognitive Function in Patients with Epilepsy Epilepsia. 2003;44(3):339-47.
    81. Guberman A, Neto W, Gassmann-Mayer C, et al. Low-dose topiramate in adults with treatment resistant partial-onset seizures. Acta Neurol Scand. 2002;106:183-9.
    82. Edwards KR, Potter DL, Wu SC, et al. Topiramate in the prevenrtive treatment of episodic migraine: a combined analisys from pilot, double-blind, placebo-controlled triels. CNS Spectr. 2003; 8: 428-32.
    83. Bootsma HP, Coolen F, Aldenkamp AP et al. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav. 2004;5:380-7.
    84. Mula M, Trimble MR, Sander JW. The role of hippocampal screrosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia. 2003;12:1573-7.
    85. Milošević N. Analiza faktora rizika za pojavu kognitivnih neželjenih efekata topiramata u terapiji epilepsije. Magistarska teza. Medicinski fakultet Univerziteta u Beogradu. Beograd 2009.
    86. Leach JP, Girvan J, Paul A, et al. Gabapentin and cognition: a double-blind, dose-ranging, placebo-controlled study in refractory epilepsy. J. Neurol. Neurosurg. Psychiatry. 1997;62:372-6.
    87. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR and Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002; 43: 482-90.
    88. R. Martin, K. Meador, L. Turrentine et al., Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia. 2001;42:764-71.

89. M.J. Brodie, D.W. Chadwick, H. Anhut et al., Gabapentin Study Group 945-212. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia. 2002;43:993-1000.

  1. Wolf SM, Shinnar S, Kang H, Gil KB, Moshe SL . Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia. 1995;36:1203-5.
  2. Aldenkamp AP. Cognitive side-effects of newer antiepileptic drugs relative to the established AEDS. In: Stefan H, Kramer G, Mamoli B eds. Challenge Epilepsy – New Antiepileptic Drugs. Blackwell Sci, Berlin 1998;135-50.
  3. Adkins JC, Noble S, Tiagabine. A Rewiev of its Pharmacodynamic and pharmacokinetic Propertis and Therapeutic Potential in theb menagment. Drugs. 1998;55:437-60.
  4. Kalviainen R, Aikia M,Mervaala E, et al. Long-term cognitive and EEG effects of tiagabine in drug resistant partial epilepsy. Epilepsy Res. 1996; 25: 291-7.
  5. Genton P, Guerrini R and Perucca E, Tiagabine in clinical practice. Epilepsia 2001;42:42-5.
  6. Schachter SC. Pharmacology and clinical experience with tiagabine. Expert Opin. Pharmacother. 2001;2:179-87.
  7. Kalviainen R. Long-term safety of tiagabine. Epilepsia. 2001;42:46-48.
  8. Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE and Helmstaedter C Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.Epilepsy & Behavior. 2005;6:373-81.
  9. Dodrill CB, Arnett JL, Sommerville KW and Sussmann NM. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia. 1995;36:164-173.
  10. Gillham RA, Blacklaw J, McKee PJ and Brodie MJ, Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. J. Neurol. Neurosurg. Psychiatry 1993;56:1271-5.
  11. Grunewald RA, Thompson PJ, Corcoran R, Corden Z, Jackson GD and Duncan JS, Effects of vigabatrin on partial seizures and cognitive function. J. Neurol. Neurosurg. Psychiatry 1994;57:1057-63.
  12. Kalviainen R, Aikia M, Saukkonen AM. et al., Vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: a randomized controlled study. Arch. Neurol. 1995;52:989-96.
  13. Aikia M, Kalviainen R, Sivenius J, Halonen T and Riekkinen PJ. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res. 1992;11:199-203.
  14. Serdaroglu G, Kurul S, Tutuncuoglu S. E. Dirik and B. Sarioglu, Oxcarbazepine in the treatment of childhood epilepsy. Pediatr. Neurol. 2003;28:37-41.
  15. Pennell PB, Ogaily MS and Macdonald RL. Aplastic anemia in a patient receiving felbamate for complex partial seizures. Neurology. 1995;45:456-60.
  16. Ketter TA, Malow BA, Flamini R et al., Felbamate monotherapy has stimulant-like effects in patients with epilepsy. Epilepsy Res. 1996;23:129-137.
  17. Neyens LG, Alpherts WC and Aldenkamp AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1995;19:411-419.
  18. Cho JR, Koo DL, Joo EY, Yoon SM, Ju E, Lee J, Kim DY, Hong SB Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients. Clin Neurophysiol. 2012;123(5):883-91.
  19. Bootsma HP, Aldenkamp AP, Hulsman J, Lambrechts D, Leenen L, Majoie M, The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice. Epilepsia. 2006;47:24-7.
  20. Mula M, Sander JW, Trimble MR. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam. Seizure. 2006;15:405-8.

Pages: 1 2 3 4 5 6 7 8 9 10


O časopisu Neurovesti

„Neurovesti“ predstavljaju elektronsku publikaciju Društva mladih neurologa Srbije sa besplatnim pristupom preko web-adrese www.neurovesti.org, i dinamikom objavljivanja na mesečnom nivou.

Opširnije

Kalendar dešavanja
<< Dec 2021. >>
MTWTFSS
29 30 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2
NOVO – Škola epilepsija – “Lečenje epilepsije vođeno etiologijom”
pratite-dns